| Serial Number | 88197617 |
| Word Mark | BIOCURC |
| Filing Date | Friday, November 16, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, September 17, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the stylized wording "BIOCURC" with six arced dots extending from the "I" and a design resembling a capsule in the "B". |
| Goods and Services | dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; ingredients for dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietary and nutritional supplements featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; medicated topical creams, gels, salves, sprays, powders, balms and ointments, all for use on the skin, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; ingredients used for further manufacture of topical creams, gels, salves, sprays, powders, balms and ointments, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; medicated topical creams, gels, salves, sprays, powders, balms and ointments, all for use on the skin, featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; pharmaceutical preparations for reducing inflammation, relieving aches and pains, and reducing the risk of disease; ingredients for pharmaceuticals; pharmaceutical preparations featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietetic foods adapted for medical use, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietetic beverages adapted for medical use, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietetic beverages adapted for medical use featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 4, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Boston BioPharm, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Southlake, TX 76092 |
| Event Date | Event Description |
| Thursday, September 17, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, September 17, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, March 6, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, March 6, 2020 | FINAL REFUSAL E-MAILED |
| Friday, March 6, 2020 | FINAL REFUSAL WRITTEN |
| Friday, March 6, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 6, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 2, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 29, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, August 29, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 29, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 29, 2019 | ASSIGNED TO LIE |
| Wednesday, August 21, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 21, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 21, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, February 21, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 20, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, December 5, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, December 4, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, November 20, 2018 | NEW APPLICATION ENTERED IN TRAM |